Filing Flows › Picard Medical (PMI) › Q2 2026
Picard Medical (PMI) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 19, 2026
Picard Medical (PMI) reported revenue of $3.0M for the second quarter 2026 (Q2 2026), +39% from a year earlier and +157% from the quarter before. Operating margin was -156.7%, net loss $5.7M (191.6% of revenue).
Picard Medical, Q2 2026: revenue $3.0M (+39% year over year), operating margin -156.7%, net loss $5.7M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | +157% | +39% |
| Operating profit | −$4.6M | — | — |
| Net earnings | −$5.7M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $3.0M in Q2 2026, up 39% year over year and up 157% from the previous quarter. Product was the largest line at 99% of revenue. Product added $804K year over year (up 38%), 98% of the total change.
Gross margin was 20.9%. Operating costs exceeded revenue by $4.6M, an operating margin of -156.7%. The fastest-growing cost line was Research & development (+85%). The quarter ended with a net loss of $5.7M, narrower than the previous quarter's $7.6M loss.
Operating cash flow was −$1.4M. Non-cash charges added back $45K of depreciation and amortization and $1.4M of share-based compensation. Working capital and other items added $2.9M.
Questions
What was Picard Medical's revenue in the second quarter 2026?
Picard Medical (PMI) reported revenue of $3.0M for the second quarter 2026 (Q2 2026), +39% from a year earlier and +157% from the quarter before.
Was Picard Medical profitable in the second quarter 2026?
Operating loss was $4.6M (-156.7% of revenue) and net loss $5.7M.
Source: Picard Medical 10-Q on SEC EDGAR.